Evidence map›Paper›PMID 34939011›Full record

ArticleKidney medicine

Nephrologists' Attitudes Toward Native Kidney Biopsy: A Qualitative Study.

Afolarin Amodu, Thalia Porteny, Insa M Schmidt, Keren Ladin, Sushrut S Waikar

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Context factors in clinical decision-making: a scoping review.BMC medical informatics and decision making · 2025
    Article
  7. An International Study of Variation in Attitudes to Kidney Biopsy Practice.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Afolarin AmoduSection of Nephrology, Boston University School of Medicine and Boston Medical Center, Boston.
Thalia PortenyDepartment of Occupational Therapy, Tufts University, Medford, Massachusetts.
Insa M SchmidtSection of Nephrology, Boston University School of Medicine and Boston Medical Center, Boston.
Keren LadinDepartment of Occupational Therapy, Tufts University, Medford, Massachusetts.
Sushrut S WaikarSection of Nephrology, Boston University School of Medicine and Boston Medical Center, Boston.
Brigham and Women's Hospital · USTufts University · US

Funding

ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI KRETZLER, MATTHIAS · 2017 to 2021
$21.0M
Spatial Metabolomics for Human KidneysUH3DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHARMA, KUMAR · 2019 to 2021
$2.7M
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.UH3DK114923 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ASHKAR, TAREK MAURICE, DAGHER, PIERRE C · 2019 to 2021
$2.2M
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)UH3DK114907 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HACOHEN, NIR, HODGIN, JEFFREY BENTON · 2019 to 2021
$1.8M
Single-nucleus sequencing and in situ mapping of mRNA molecules in human kidneyUH3DK114933 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAIN, SANJAY, ZHANG, KUN · 2019 to 2021
$1.8M
Multidimensional cellular interrogation of the kidney in AKI and CKDUH3DK114937 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LASZIK, ZOLTAN · 2019 to 2021
$1.2M
Harvard Chronic Kidney Disease Research Biopsy CenterUH3DK114915 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSAS, SYLVIA E, WAIKAR, SUSHRUT S. · 2019 to 2021
$900k
Cleveland Precision Medicine Chronic Kidney Disease CohortUH3DK114908 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI O'TOOLE, JOHN F., POGGIO, EMILIO DANIEL · 2019 to 2021
$900k
Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment SiteUH3DK114926 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARASCH, JONATHAN M., BOMBACK, ANDREW STEPHEN · 2019 to 2021
$900k
Phenotyping REnal Cases In Sepsis and surgery for Early Acute Kidney Injury (PReCISE AKI)UH3DK114861 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLUM, JOHN A, PALEVSKY, PAUL M · 2019 to 2021
$900k
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)UH3DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PARIKH, CHIRAG R · 2019 to 2021
$900k
Chronic Kidney Disease Precision Medicine ProjectUH3DK114870 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL, VAZQUEZ, MIGUEL A · 2019 to 2021
$900k
NIDDK NIH HHS U2C DK114886NIDDK NIH HHS UH3 DK114861NIDDK NIH HHS UH3 DK114866NIDDK NIH HHS UH3 DK114870NIDDK NIH HHS UH3 DK114907NIDDK NIH HHS UH3 DK114908NIDDK NIH HHS UH3 DK114915NIDDK NIH HHS UH3 DK114920NIDDK NIH HHS UH3 DK114923NIDDK NIH HHS UH3 DK114926NIDDK NIH HHS UH3 DK114933NIDDK NIH HHS UH3 DK114937
6 · The paper itself

Abstract

RATIONALE &

objectiveAlthough kidney biopsy is a useful tool, nephrologists' approach toward biopsies is inconsistent for reasons incompletely understood, including lack of established clinical guidelines. We examined contemporary clinical decision-making patterns among nephrologists to perform native kidney biopsy. STUDY

designQualitative study using semistructured interviews. SETTING &

participantsPurposive sampling was used to select nephrologists from different regions in the United States. Semistructured interviews were continued until thematic saturation. ANALYTICAL APPROACH: A modified grounded theory was used to identify dominant themes reflecting the nephrologists' decision-making styles about kidney biopsy.

resultsTwenty nephrologists were interviewed: 16 (80%) were from academic centers, 3 (15%) performed their own biopsies, and 7 (35%) had been in practice for less than 10 years. The median time of practice was 14 years. We found substantial variability among the nephrologists in their attitude toward using kidney biopsy, which reflected individual differences in weighing the risks and benefits of the procedure for an individual patient. Five overarching themes were identified: operator comfort with biopsy and availability of interventional radiologist, exposure to biopsy during training and years of experience, concerns about the invasiveness of biopsy and inflicting harm, perception of evidence base and limited treatment options, and patient characteristics and preference. LIMITATIONS: Generalizability was limited because the nephrologists sampled may not have been broadly representative.

conclusionsMultiple factors influence nephrologists' decision to pursue kidney biopsy, with substantial variability among nephrologists that can have meaningful clinical implications. This suggests the need to establish consensus guidelines to make biopsy practice more standardized.

Indexed as

Biopsy guidelineclinical biopsyindications for kidney biopsykidney biopsyphysician attitudequalitative researchrenal biopsy

Identifiers

PMID34939011
PMCPMC8664729
OpenAlexW3199145991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.